Melanoma Journal Articles for August 2019

Dermatology Online Journal

Melanoma screening using patient self-assessed risk and total body photography

2019

Drugge, Elizabeth D, Okundaye, Osatohamwen I, Sarac, Rebecca M, Drugge, Rhett J

https://escholarship.org/uc/item/33h4r9bk


Dermatology Online Journal

Melanoma screening using patient self-assessed risk and total body photography

2019

Drugge, Elizabeth D, Okundaye, Osatohamwen I, Sarac, Rebecca M, Drugge, Rhett J

https://escholarship.org/uc/item/33h4r9bk


British Journal of Dermatology

Development and external validation study of a melanoma risk prediction model incorporating clinically?assessed naevi and solar lentigines

  1. VuongB.K. Armstron, M. Drummond, J.L. Hopper, J.H. Barrett, J.R. Davies, D.T. Bishop, J. Newton?Bishop, J.F. Aitken, G.G. Giles, H. Schmid, M.A. Jenkins, G.J. Mann, K. McGeechan, A.E. Cust

First published: 04 August 2019

https://doi.org/10.1111/bjd.18411


JAMA Network Open

Original Investigation 

Cardiology

August 9, 2019

Cardiovascular Adverse Events Associated With BRAF and MEK InhibitorsA Systematic Review and Meta-analysis

Raluca I. Mincu, PhD1Amir A. Mahabadi, MD1Lars Michel, MD1; et alSimone M. Mrotzek, MD1Dirk Schadendorf, MD2Tienush Rassaf, MD1Matthias Totzeck, MD1

JAMA Netw Open. 2019;2(8):e198890. doi:10.1001/jamanetworkopen.2019.8890


JNCI Cancer Spectr. 2019 Jan 9;2(4):pky068. doi: 10.1093/jncics/pky068. eCollection 2018 Oct.

Familial Risks and Mortality in Second Primary Cancers in Melanoma.

Chattopadhyay S1Hemminki A2,3Försti A1,3Sundquist K3,4,5Sundquist J6,4,5Hemminki K6.


Dove Press

Long noncoding RNA HCP5 suppresses skin cutaneous melanoma development by regulating RARRES3 gene expression via sponging miR-12

Authors Wei X, Gu X, Ma M, Lou C

Received 23 November 2018

Accepted for publication 1 March 2019

Published 12 August 2019 Volume 2019:12 Pages 6323—6335

DOI https://doi.org/10.2147/OTT.S195796


Journal of Immunotherapy

Prognostic Significance of Hematological Indices in Malignant Melanoma Treated With Immune Checkpoint Inhibitors

Afzal, Muhammad Z.*; Sarwar, Tayyaba; Shirai, Keisuke

Journal of Immunotherapy: September 2019 – Volume 42 – Issue 7 – p 251–264

doi: 10.1097/CJI.0000000000000272

Clinical Studies


Dove Press

Typical electronegative electroretinography and nyctalopia as a presenting feature of systemic malignant melanoma

Authors Vercio A, Chalam KV, Winter T

Received 14 January 2019

Accepted for publication 9 July 2019

Published 13 August 2019 Volume 2019:12 Pages 265—276

DOI https://doi.org/10.2147/IMCRJ.S201500


International Journal of Cancer

Cancer Epidemiology

 Full Access

Postmenopausal hormone use and cutaneous melanoma risk: A French prospective cohort study

  1. Cervenka, M. Al Rahmoun, Y. Mahamat?Saleh, I. Savoye, M.C. Boutron?Ruault, A. Fournier,
  2. Kvaskoff

First published: 22 January 2019       https://doi.org/10.1002/ijc.32150


The Lancet

ARTICLES| VOLUME 394, ISSUE 10197, P471-477, AUGUST 10, 2019

2-cm versus 4-cm surgical excision margins for primary cutaneous melanoma thicker than 2 mm: long-term follow-up of a multicentre, randomised trial

Deborah Utjés, MD, Jonas Malmstedt, MD, Jüri Teras, MD, Prof Krzysztof Drzewiecki, MD, Hans Petter Gullestad, MD, Prof Christian Ingvar, MD, et al.

Published:July 04, 2019DOI:https://doi.org/10.1016/S0140-6736(19)31132-8


REVIEW

 Open Access

Clinical outcomes of BRAF plus MEK inhibition in melanoma: A meta?analysis and systematic review

Qingliang Yu, Jiayi Xie, Jiangmiao Li, Yunxin Lu, Liang Liao

First published: 08 August 2019       https://doi.org/10.1002/cam4.2248


Cancer

Original Article  Full Access

Incidence, patterns of progression, and outcomes of preexisting and newly discovered brain metastases during treatment with anti–PD?1 in patients with metastatic melanoma

Gustavo Schvartsman MD, Junsheng Ma PhD, Roland L. Bassett Jr MS, Lauren E. Haydu PhD, Rodabe Navroze Amaria MD, Patrick Hwu MD, Michael K. Wong MD, PhD, et., al.

First published: 09 August 2019    https://doi.org/10.1002/cncr.32454


Whole brain radiotherapy (WBRT) after local treatment of brain metastases in melanoma patients: Statistical Analysis Plan

Trialsvolume 20, Article number: 477 (2019)


Translational Oncology

Targeted Radionuclide Therapy Decreases Melanoma Lung Invasion by Modifying Epithelial-Mesenchymal Transition-Like Mechanisms?

HusseinAkil*1JacquesRouanet*†‡1ClaireViallard*SophieBesse*PhilippeAuzeloux*Jean-MichelChezal*ElisabethMiot-Noirault*MercedesQuintana*FrançoiseDegoula

https://doi.org/10.1016/j.tranon.2019.07.015


British Journal of Dermatology

Genetic Alterations in Primary Melanoma in Taiwan

Y.?S. Sheen, K.?T. Tan, K.?P. Tse, Y.?H. Liao, M.?H. Lin, J.?S. Chen, J.?Y. Liau, Y.?J. Tseng, C.?H. Lee, C.?H. Hong, J.?B. Liao, H.?T. Chang, C.?Y. Chu

First published: 13 August 2019    https://doi.org/10.1111/bjd.18425


JAMA Dermatology

Original Investigation

May 15, 2019

Patients’ Views About Skin Self-examination After Treatment for Localized Melanoma

Mbathio Dieng, PhD1,2Amelia K. Smit, MPH2,3Jolyn Hersch, PhD4; et alRachael L. Morton, PhD1,2Anne E. Cust, PhD2,3Les Irwig, PhD4Donald Low5Cynthia Low, MLitt5Katy J. L. Bell, PhD4

Author Affiliations Article Information

JAMA Dermatol. 2019;155(8):914-921. doi:10.1001/jamadermatol.2019.0434


New England Journal of Medicine

Five-Year Outcomes with Dabrafenib plus Trametinib in Metastatic Melanoma

Caroline Robert, M.D., Ph.D., Jean J. Grob, M.D., Ph.D., Daniil Stroyakovskiy, M.D., Boguslawa Karaszewska, M.D., Axel Hauschild, M.D., Evgeny Levchenko, M.D., Vanna Chiarion Sileni, M.D., Jacob Schachter, M.D., Claus Garbe, M.D., Igor Bondarenko, M.D., Ph.D., Helen Gogas, M.D., Mario Mandalá, M.D., et al.

August 15, 2019
N Engl J Med 2019; 381:626-636     DOI: 10.1056/NEJMoa1904059


Original Article

No association between smoking and sentinel lymph node metastasis and survival in cutaneous melanoma

  1. Tejera?VaquerizoM.A. Descalzo?Gallego, V. Traves, C. Requena, I. Bolumar, A. Pla, E. Nagore

First published: 08 July 2019     https://doi.org/10.1111/jdv.15789


BMC Cancer Cell International

NEAT1/miR-23a-3p/KLF3: a novel regulatory axis in melanoma cancer progression

Fei DingJindong LaiYang GaoGenhui WangJingwen ShangDaojun Zhang & Shumao Zheng


JAMA Dermatology

Original Investigation

August 28, 2019

Evolution of Excisional Surgery Practices for Melanoma in the United States

Michael P. Lee, BS1Joseph F. Sobanko, MD2Thuzar M. Shin, MD, PhD2; et alNicole M. Howe, MD2John S. Barbieri, MD2Christopher J. Miller, MD2Jeremy R. Etzkorn, MD2

Author Affiliations

JAMA Dermatol. Published online August 28, 2019. doi:10.1001/jamadermatol.2019.2346


JAMA Dermatology

Viewpoint

August 28, 2019

Mohs Micrographic Surgery for MelanomaAs Use Increases, So Does the Need for Best Practices

Christopher J. Miller, MD1Cerrene N. Giordano, MD2H. William Higgins II, MD, MBE3

Author Affiliations

JAMA Dermatol. Published online August 28, 2019. doi:10.1001/jamadermatol.2019.2589


Cancer Immunology Research

STING signaling in melanoma cells shapes antigenicity and can promote antitumor T-cell activity

Rana Falahat, Patricio Perez-Villarroel, Adam W Mailloux, Genyuan Zhu, Shari Pilon-Thomas, Glen N Barber and James J Mulé

Published Online First August 28, 2019  DOI: 10.1158/2326-6066.CIR-19-0229


BioRxiv

Targeting effector pathways in RAC1P29S-driven malignant melanoma

Cristina Uribe-Alvarez, Sandra Lucía Guerrero-Rodríguez, Jennifer Rhodes, Alexa Cannon,  View ORCID ProfileJonathan Chernoff, Daniela Araiza-Olivera

doi: https://doi.org/10.1101/750489


Journal of Extracellular Vesicles

Mitochondrial protein enriched extracellular vesicles discovered in human melanoma tissues can be detected in patient plasma

Su Chul Jang,Rossella Crescitelli,Aleksander Cvjetkovic,Valerio Belgrano,Roger Olofsson Bagge,Karin Sundfeldt,Takahiro Ochiya,Raghu Kalluri &Jan Lötvall show less

Article: 1635420 | Received 12 May 2018, Accepted 14 Jun 2019, Published online: 27 Aug 2019